2011
DOI: 10.2147/jmdh.s7108
|View full text |Cite
|
Sign up to set email alerts
|

Multidisciplinary care in pediatric oncology

Abstract: This paper describes the significant advances in the treatment of childhood cancer and supportive care that have occurred over the last several decades and details how these advances have led to improved survival and quality of life (QOL) for children with cancer through a multidisciplinary approach to care. Advances in the basic sciences, general medicine, cooperative research protocols, and policy guidelines have influenced and guided the multidisciplinary approach in pediatric oncology care across the spect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 61 publications
0
25
0
1
Order By: Relevance
“…They are responsible for all children (0–15 years) diagnosed with cancer though, for individual patients, specific aspects of care may be delivered by a district general hospital closer to the child's home (known as Paediatric Oncology Shared Care Unit). As in other developed countries (Cantrell & Ruble, ), paediatric oncology services in the UK are delivered by a multidisciplinary team (NICE, ). We were interested in staff support systems and practices across the MDT with respect to the following staff group categories: nurses, doctors, other health professionals in the MDT (e.g.…”
Section: Methodsmentioning
confidence: 99%
“…They are responsible for all children (0–15 years) diagnosed with cancer though, for individual patients, specific aspects of care may be delivered by a district general hospital closer to the child's home (known as Paediatric Oncology Shared Care Unit). As in other developed countries (Cantrell & Ruble, ), paediatric oncology services in the UK are delivered by a multidisciplinary team (NICE, ). We were interested in staff support systems and practices across the MDT with respect to the following staff group categories: nurses, doctors, other health professionals in the MDT (e.g.…”
Section: Methodsmentioning
confidence: 99%
“…Research to date examines the safety, efficacy, and outcomes of individual complementary medicines; determines safe and effective dosing recommendations for various substances; elucidates mechanisms of action of specific substances; and highlights possible interactions with mainstream biomedical therapies. 9 Despite this growing body of research, limited data prevents clear understanding of the effects of various complementary medicine agents and thereby makes complementary medicine use an uncontrolled variable in clinical trials. Importantly, the pediatric oncology scientific community has not focused on communicating to the public the scientific rationale and/or evidence for and against various complementary medicines.…”
Section: The Growing Use Of Complementary Medicine In Pediatric Oncologymentioning
confidence: 99%
“…[ 5 6 ] These processes may lead to emotional distress, functional limitations, participation restrictions, and confined adaptive skills and responses in these children. [ 7 8 ] Children hospitalized in pediatric oncology wards may experience negative sign and symptoms such as developmental delay, sleep disorders, eating disorders, aggression, anxiety, depression, dependency on caregivers, disruption of daily activities, diminished quality of life, and limited participation in social functions. [ 9 10 ]…”
Section: Introductionmentioning
confidence: 99%